PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
08-Jul-2025 Longevity Method Launches to Transform Health and Wellness with Innovative Anti-Aging Solutions ACCESS Newswire
08-Jul-2025 Infusion Pump Market Size & Share | Growth Analysis 2035 VMR
08-Jul-2025 Invitation to Presentation of Senzime's Second Quarter 2025 Report ACCESS Newswire
08-Jul-2025 Boca Recovery Center Announces New Addiction Treatment Center in Springfield, Mass. ACCESS Newswire
08-Jul-2025 MMJ International Redefines Medical Cannabis with First Plant-Based Drug for a Rare Neurological Disease ACCESS Newswire
08-Jul-2025 Hyaluronic Acid Dermal Filler Market Poised to Surpass USD 10.8 Billion by 2033 Amid Rising Demand for Minimally Invasive Aesthetic Treatments Ameco Research
08-Jul-2025 Global Metaverse in Medical Training Market to See 8–9% CAGR Growth With Rising EdTech Demand by 2029 MediTech-Insights
08-Jul-2025 Global AI in Precision Medicine Market to Achieve 25–30% CAGR Amid Precision Health Demand by 2029 MediTech-Insights
08-Jul-2025 AI in Life Sciences Market to grow at 25% CAGR driven by drug innovation and analytics by 2029 MediTech-Insights
08-Jul-2025 Global Medication Management Market to grow at 8–9% CAGR with tech advances and trends by 2029 MediTech-Insights
08-Jul-2025 Angle PLC Announces Parsortix Enables Study Of Cancer Progression ACCESS Newswire
08-Jul-2025 Lobe Sciences Announces Validation of European Unitary Patent for DHA-Based Composition for Sickle Cell Disease ACCESS Newswire
07-Jul-2025 Sports Injuries Made Every Day a Mortal Struggle Until The Spero Clinic Began Treatment: Kole Jackson's Story ACCESS Newswire
07-Jul-2025 First patient dosed in the Phase I clinical trial of PulseSight Therapeutics’ PST-611 treatment for dry AMD/Geographic Atrophy Pulsesight Therapeutics
07-Jul-2025 Psyence Group Inc. Closes Second Tranche of Non‑Brokered Private Placement for Remaining Proceeds ACCESS Newswire
07-Jul-2025 MicroGenDX Transforms Infectious Disease Diagnostics With Innovative 24-Hour Testing Technology ACCESS Newswire
07-Jul-2025 Eleva administers first dose of its Factor H biological treatment in C3-Glomerulopathy to healthy volunteers Eleva
07-Jul-2025 ONWARD Medical Adds Entrepreneur and Neurotechnology Thought Leader Tim Denison, PhD to its Board of Directors Onward Medical
07-Jul-2025 CYP17A1 Inhibitors Market to Reach USD 1.35 Billion by 2025, Fueled by Advancements in Prostate Cancer Therapeutics globenewswireonlione
07-Jul-2025 Tendonitis Treatment Market Crosses USD 223.7 Billion in 2024, Set to Surge Beyond USD 308 Billion by 2033 with Advancements in Regenerative Therapies Acumen Research and Consulting